Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Application Products
001 | TABLET, EXTENDED RELEASE; ORAL | 250MG | 0 | DEPAKOTE ER | DIVALPROEX SODIUM |
002 | TABLET, EXTENDED RELEASE; ORAL | 500MG | 0 | DEPAKOTE ER | DIVALPROEX SODIUM |
FDA Submissions
TYPE 6; Type 6 - New Indication (no longer used) | ORIG | 1 | AP | 2008-03-24 | PRIORITY |
Submissions Property Types
CDER Filings
ABBVIE INC
cder:Array
(
[0] => Array
(
[ApplNo] => 22267
[companyName] => ABBVIE INC
[docInserts] => ["",""]
[products] => [{"drugName":"DEPAKOTE ER","activeIngredients":"DIVALPROEX SODIUM","strength":"250MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"DEPAKOTE ER","activeIngredients":"DIVALPROEX SODIUM","strength":"500MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"10\/15\/2009","submission":"SUPPL-1","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2009\\\/022267s001lbl.pdf\"}]","notes":""},{"actionDate":"03\/24\/2008","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2008\\\/022267lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"DEPAKOTE ER","submission":"DIVALPROEX SODIUM","actionType":"250MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"DEPAKOTE ER","submission":"DIVALPROEX SODIUM","actionType":"500MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 2009-10-15
)
)